Tus kws kho mob
Upcoming pharmacy program policy activity effective Nov. 1, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2371 - 2380 ntawm 3685
Tus kws kho mob
P81-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
QP50-19 Pharmacy Benefit Exclusion for Intramuscular Route of Administration Medications
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019
Tus kws kho mob
QP105-20 Update: EquiClaim to Perform Focused and Limited Hospital Bill Validation (HBV) Services
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 28, 2020
Tus kws kho mob
P85-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
P80-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective January 4, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
P82-20 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
QP100-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor IX PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP95-20 Commercial Pharmacy Benefit Exclusion for Jelmyto®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020